Skip to search formSkip to main contentSkip to account menu

MVAp53 vaccine

Known as: Modified Vaccinia Virus Ankara Vaccine Expressing p53, MVA-p53, MVA-p53 Vaccine 
A cancer vaccine comprised of a recombinant modified vaccinia Ankara (MVA) viral vector encoding the wild-type form of the tumor protein p53 (wt p53… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Cancer Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Efficacy, feasibility and patient acceptability of ultrasound‐guided manual vacuum aspiration for treating early pregnancy loss
Ultrasound‐guided manual vacuum aspiration (USG‐MVA) is an effective but underutilised alternative to medical or surgical… 
2018
2018
Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B
An effective vaccine against Human Immunodeficiency Virus (HIV) still remains the best solution to provide a sustainable control… 
2016
2016
Balance between activation and regulation of HIV-specific CD8+ T-cell response after modified vaccinia Ankara B therapeutic vaccination
Background:The causes of HIV-vaccines failure are poorly understood. Therapeutic vaccination with modified vaccinia Ankara (MVA… 
2015
2015
Construction of FWPV Chimaeric MVA.
Construction of chimaeric MVA is a useful tool with which to study gene function of related viruses. The protocol given here… 
2014
2014
Overcoming immunosuppression to enhance a p53MVA vaccine
A Phase I trial of a p53-targeting modified vaccinia Ankara (p53MVA) vaccine in patients afflicted with refractory… 
Review
2014
Review
2014
A comprehensive protection scheme for generator loss of excitation
Power system is constantly evolving with application of new technology to improve the reliability and security of the system. At… 
2010
2010
A Pandemic Influenza H1N1 Live Vaccine Based on Modified Vaccinia Ankara Is Highly Immunogenic and Protects Mice in Active and Passive Immunizations
Background The development of novel influenza vaccines inducing a broad immune response is an important objective. The aim of… 
2009
2009
The expression of the soluble isoform of hFlt3 ligand by recombinant vaccinia virus enhances immunogenicity of the vector.
Recombinant vaccinia viruses (rVACV) expressing various tumor-associated antigens have been shown to elicit anti-tumor effect in… 
2005
2005
A 16 MVA ANPC-PEBB with 6 kA IGCTs
The integrated gate commutated thyristor (IGCT) has steadily gained importance on the market since its introduction in 1996. Low… 
Highly Cited
2000
Highly Cited
2000
Comparative Efficacy of Recombinant Modified Vaccinia Virus Ankara Expressing Simian Immunodeficiency Virus (SIV) Gag-Pol and/or Env in Macaques Challenged with Pathogenic SIV
ABSTRACT Prior studies demonstrated that immunization of macaques with simian immunodeficiency virus (SIV) Gag-Pol and Env… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)